Per Kogner

12.2k total citations
232 papers, 7.7k citations indexed

About

Per Kogner is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Per Kogner has authored 232 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Neurology, 113 papers in Molecular Biology and 68 papers in Cancer Research. Recurrent topics in Per Kogner's work include Neuroblastoma Research and Treatments (172 papers), Cancer, Hypoxia, and Metabolism (61 papers) and Neuroendocrine Tumor Research Advances (40 papers). Per Kogner is often cited by papers focused on Neuroblastoma Research and Treatments (172 papers), Cancer, Hypoxia, and Metabolism (61 papers) and Neuroendocrine Tumor Research Advances (40 papers). Per Kogner collaborates with scholars based in Sweden, United States and Norway. Per Kogner's co-authors include John Inge Johnsen, Tommy Martinsson, Baldur Sveinbjørnsson, Helena Carén, Frida Ponthan, Frida Abel, Lova Segerström, Ninib Baryawno, Guðmundur H. Guðmundsson and Jacob Odeberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Per Kogner

225 papers receiving 7.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Per Kogner 4.1k 3.1k 2.1k 1.7k 885 232 7.7k
Michelle Haber 5.4k 1.3× 2.5k 0.8× 2.0k 1.0× 3.4k 2.1× 693 0.8× 229 9.8k
Scott S. Zamvil 3.4k 0.8× 2.0k 0.7× 741 0.4× 2.3k 1.4× 818 0.9× 191 15.4k
Paul H. Weinreb 3.4k 0.8× 1.2k 0.4× 455 0.2× 950 0.6× 466 0.5× 78 7.8k
Carol J. Thiele 4.8k 1.2× 2.6k 0.8× 1.4k 0.7× 1.5k 0.9× 466 0.5× 159 7.7k
Rui Li 2.3k 0.6× 497 0.2× 1.3k 0.6× 926 0.6× 710 0.8× 244 6.3k
Markus Glatzel 5.5k 1.3× 943 0.3× 891 0.4× 932 0.6× 494 0.6× 294 9.7k
Pam Fredman 4.3k 1.0× 1.4k 0.5× 326 0.2× 558 0.3× 557 0.6× 177 8.0k
Florence M. Hofman 2.9k 0.7× 628 0.2× 728 0.4× 1.4k 0.8× 2.0k 2.3× 172 9.6k
Hiroshi Nagura 2.2k 0.5× 728 0.2× 886 0.4× 2.2k 1.3× 788 0.9× 245 8.7k
Lawrence Helson 2.3k 0.6× 1.6k 0.5× 529 0.3× 1.2k 0.7× 452 0.5× 157 6.0k

Countries citing papers authored by Per Kogner

Since Specialization
Citations

This map shows the geographic impact of Per Kogner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Kogner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Kogner more than expected).

Fields of papers citing papers by Per Kogner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Kogner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Kogner. The network helps show where Per Kogner may publish in the future.

Co-authorship network of co-authors of Per Kogner

This figure shows the co-authorship network connecting the top 25 collaborators of Per Kogner. A scholar is included among the top collaborators of Per Kogner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Kogner. Per Kogner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Juan, Jiacheng Zhu, Wenyu Li, et al.. (2025). HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma. Proceedings of the National Academy of Sciences. 122(43). e2516922122–e2516922122.
2.
3.
Geller, James I., Martine van Grotel, Marc Ansari, et al.. (2024). Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer. SHILAP Revista de lepidopterología. 5. 100211–100211.
4.
Delgado-Vega, A M, Fulya Taylan, Kristina Lagerstedt‐Robinson, et al.. (2024). Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature. American Journal of Medical Genetics Part A. 194(12). e63812–e63812.
5.
Treis, Diana, Emma Åkerlund, Brinton Seashore‐Ludlow, et al.. (2024). The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma. Cancer Letters. 605. 217261–217261. 2 indexed citations
6.
Mei, Shenglin, Bronte Manouk Verhoeven, Ting Zhao, et al.. (2024). Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature. JCI Insight. 9(6). 8 indexed citations
7.
Vaid, Roshan, Rebeca Burgos‐Panadero, Anna Djos, et al.. (2023). METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Research. 52(5). 2648–2671. 27 indexed citations
8.
Djos, Anna, Roshan Vaid, Ganesh Umapathy, et al.. (2023). Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes. Cancers. 15(24). 5732–5732. 3 indexed citations
9.
Olsen, Thale Kristin, Cecilia Dyberg, Jelena Milosevic, et al.. (2022). DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma. JCI Insight. 7(17). 21 indexed citations
10.
Milosevic, Jelena, Diana Treis, Susanne Fransson, et al.. (2021). PPM1D Is a Therapeutic Target in Childhood Neural Tumors. Cancers. 13(23). 6042–6042. 7 indexed citations
11.
Milosevic, Jelena, Susanne Fransson, Miklós Gulyás, et al.. (2021). High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice. Cancers. 13(21). 5493–5493. 8 indexed citations
12.
Blomqvist, Lennart, Yvonne Brandberg, Niklas Pal, et al.. (2020). Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53. Hereditary Cancer in Clinical Practice. 18(1). 1–1. 6 indexed citations
13.
Wickström, Malin, Peter J. Coopman, Per Kogner, et al.. (2019). SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro. Cancers. 11(2). 202–202. 7 indexed citations
14.
Mao, Yumeng, Nina Eißler, Katarina Le Blanc, et al.. (2016). Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma. Clinical Cancer Research. 22(15). 3849–3859. 107 indexed citations
15.
Chen, Zhi Xiong, Karin Wallis, Daniel Ramsköld, et al.. (2014). RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma. Cancer Discovery. 4(4). 434–451. 43 indexed citations
16.
Ladenstein, Ruth, Ulrike Pöetschger, Roberto Luksch, et al.. (2011). Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study. IRIS. 1 indexed citations
17.
Martinsson, Tommy, Therése Eriksson, Jonas Abrahamsson, et al.. (2010). Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy. Cancer Research. 71(1). 98–105. 59 indexed citations
18.
Baryawno, Ninib, Baldur Sveinbjørnsson, Staffan Eksborg, et al.. (2009). Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth. Cancer Research. 70(1). 266–276. 118 indexed citations
19.
Carén, Helena, Frida Abel, Per Kogner, & Tommy Martinsson. (2008). High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours. Biochemical Journal. 416(2). 153–159. 202 indexed citations
20.
Martinsson, Tommy, Edneia Tani, Sture Falkmer, et al.. (1999). The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Cancer. 87(2). 60–68. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Haber Breakdown of academic impact, for papers by Scott S. Zamvil Breakdown of academic impact, for papers by Paul H. Weinreb Breakdown of academic impact, for papers by Carol J. Thiele Breakdown of academic impact, for papers by Rui Li Breakdown of academic impact, for papers by Markus Glatzel Breakdown of academic impact, for papers by Pam Fredman Breakdown of academic impact, for papers by Florence M. Hofman Breakdown of academic impact, for papers by Hiroshi Nagura Breakdown of academic impact, for papers by Lawrence Helson
Rankless by CCL
2026